Figure 4.
G-APOD representation of COVID-19 related drugs in clinical trials. (A) Molnupiravir (B) Dexamethasone (C) Lopinavir. The drugs were classified into three categories of safety profiles: strong, moderate and weak.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.